Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.
Han JW, Sung PS, Yoo JS, Cho HS, Lee SK, Yang H, Kim JH, Nam H, Lee HL, Kim HY, Lee SW, Song DS, Song MJ, Kwon JH, Kim CW, Bae SH, Jang JW, Choi JY, Yoon SK.
Han JW, et al. Among authors: cho hs.
Front Oncol. 2024 Feb 28;14:1372007. doi: 10.3389/fonc.2024.1372007. eCollection 2024.
Front Oncol. 2024.
PMID: 38482199
Free PMC article.